Clinical Trial Update: Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating granulocyte colony-stimulating factor and erythropoietin for acute-on-chronic liver failure has completed, with efficacy results report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Erythropoietin (erythropoietin)
• Filgrastim (filgrastim)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute on Chronic Hepatic Failure | Phase 3 | Status: COMPLETED